Related Experiment Videos
Summary
Naltrexone, an opioid addiction treatment, is a long-acting narcotic antagonist approved by the FDA. This review explores its uses and optimal administration for managing opioid dependence.
Area of Science:
- Pharmacology
- Addiction Medicine
- Clinical Therapeutics
Background:
- Naltrexone (Trexan R) is an orally effective, long-acting narcotic antagonist.
- It received Food and Drug Administration (FDA) approval in November 1984.
- Its primary indication is as an adjunct in the treatment of opioid addiction.
Purpose of the Study:
- To review current knowledge regarding naltrexone.
- To elucidate the most appropriate methods for utilizing naltrexone in clinical practice.
Main Methods:
- Literature review of existing research on naltrexone.
- Analysis of clinical guidelines and expert recommendations for naltrexone use.
Main Results:
- Naltrexone functions as a competitive antagonist at opioid receptors.
- Its efficacy is demonstrated in reducing opioid craving and relapse rates when used consistently.
- Appropriate patient selection and adherence monitoring are crucial for successful outcomes.
Conclusions:
- Naltrexone is a valuable tool in comprehensive opioid addiction treatment programs.
- Further research may refine optimal dosing and long-term management strategies.
- Effective utilization requires careful patient counseling and support.